US EditionBiovac starts trials on South Africa's first domestically developed cholera vaccine
The vaccine targets Africa’s cholera outbreaks amid global shortages, with trials in three provinces aiming for approval by 2028, officials said.
10 Articles
10 Articles
SA starts ground-breaking clinical trials for oral cholera vaccine - Juta MedicalBrief
Clinical trials testing the efficacy of the first locally manufactured oral cholera vaccine, developed by Biovac, were officially launched on Tuesday, reports TimesLIVE – which if successful, will make South Africa the first country on the continent to manufacture the vaccine entirely from start to finish. Co-ordinated by the South African Medical Research Council (SAMRC), the trials will take place across various sites, including KwaZulu-Natal …
South Africa tests first indigenous cholera vaccineSouth Africa has begun clinical trials of the first indigenous cholera vaccine, developed by pharmaceutical company Biovac. The oral vaccine is initially being tested for safety in adults and will later be compared with drugs already on the market.
Nairobi, Kenya. South Africa announced Tuesday the start of a clinical trial for the first cholera vaccine developed from start to finish at the local level, in a new step to remedy the continent’s high dependence on the outside to obtain its drugs. The South African vaccine manufacturer Biovac, based in Cape Town, has received approval from the South African Health Product Regulatory Authority (SAHPRA) to begin the first phase of trials of its …
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
